[A case of ticlopidine-associated thrombotic thrombocytopenic purpura: special emphasis on diffusion weighted MRI]

Nozomu Matsuda1, Akiko Yoshihara, Rie Nishikata

  • 1Department of Neurolgy, Fukushima Medical University.

Insights

This case report details a patient with thrombotic thrombocytopenic purpura (TTP) linked to ticlopidine, presenting with neurological symptoms and characteristic lab findings. Prompt plasma exchange and identification of low ADAMTS13 activity supported the diagnosis and treatment.

Area of Science:

  • Neurology
  • Hematology
  • Pharmacology

Background:

  • Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening thrombotic microangiopathy.
  • Ticlopidine, an antiplatelet agent, has been associated with TTP in previous reports.
  • Understanding the neurological manifestations and imaging findings in drug-induced TTP is crucial for timely diagnosis and management.

Observation:

  • A 69-year-old male developed TTP with neurological deficits, including dysarthria and hemiparesis, after ticlopidine administration.
  • Clinical presentation included altered consciousness, fever, purpura, thrombocytopenia, hemolytic anemia, and renal dysfunction.
  • Serial diffusion-weighted MRI revealed transient, scattered high-intensity lesions in the brain, consistent with border-zone infarcts.

Findings:

  • The patient's TTP was confirmed by Moschcowitz's criteria, with decreased ADAMTS13 activity and positive anti-ADAMTS13 antibodies.
  • Neurological findings on MRI, specifically the appearance and disappearance of lesions in border-zone distributions, are a key observation.
  • This case aligns with MRI findings classified as multiple microthrombi-induced infarctions in TTP.

Implications:

  • The study suggests TTP may predispose individuals to border-zone-like infarctions, potentially due to vascular resistance or impaired emboli clearance.
  • This case highlights the importance of considering drug-induced TTP in patients presenting with neurological symptoms and microangiopathic hemolytic anemia.
  • Diffusion-weighted MRI is a valuable tool for characterizing the cerebrovascular changes in TTP and guiding therapeutic strategies.